4//SEC Filing
ASELAGE STEVE 4
Accession 0001209191-21-065439
CIK 0001438533other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:08 PM ET
Size
5.6 KB
Accession
0001209191-21-065439
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Sale
Common Stock
2021-11-16$29.39/sh−31,800$934,602→ 149,494 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $29.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Includes 19,500 shares previously reported as indirectly held in the name of the Aselage Family Trust.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001221599
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:08 PM ET
- Size
- 5.6 KB